Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders
Abstract
1. Introduction
2. Methods
2.1. Data Source
2.2. Inclusion Criteria and Variables
2.3. Statistical Analysis
2.4. Ethical Approval
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Prevention, Centers for Disease Control and Prevention. Today’s Heroin Epidemic. 2015. Available online: https://www.cdc.gov/vitalsigns/heroin/index.html (accessed on 15 April 2019).
- Results from the 2017 National Survey on Drug Use and Health: Detailed Tables. 2018. Available online: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf (accessed on 15 April 2019).
- Huang, X.; Keyes, K.M.; Li, G. Increasing Prescription Opioid and Heroin Overdose Mortality in the United States, 1999–2014: An Age-Period-Cohort Analysis. Am. J. Public Health 2018, 108, 131–136. [Google Scholar] [CrossRef] [PubMed]
- Results from the 2015 National Survey on Drug Use and Health: Detailed Tables. 2016. Available online: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf (accessed on 15 April 2019).
- Association, Associated Press. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; Psychiatric Publishing: Arlington, VA, USA, 2015. [Google Scholar]
- Moses, T.E.H.; Lundahl, L.H.; Greenwald, M.K. Factors associated with sedative use and misuse among heroin users. Drug Alcohol Depend. 2018, 185, 10–16. [Google Scholar] [CrossRef] [PubMed]
- Case, A.; Deaton, A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc. Natl. Acad. Sci. USA 2015, 112, 15078–15083. [Google Scholar] [CrossRef]
- Curtin, S.C.; Tejada-Vera, B.; Warner, M. Drug Overdose Deaths among Adolescents Aged 15–19 in the United States: 1999–2015; National Center for Health Statistics: Hyattsville, MD, USA, 2017.
- McCabe, S.E.; Veliz, P.; Boyd, C.J.; Schulenberg, J.E. Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents’ use and substance use disorder symptoms in adulthood. Addict. Behav. 2017, 65, 296–301. [Google Scholar] [CrossRef] [PubMed]
- Healthcare Cost and Utilization Project (HCUP) (Ed.) HCUP NIS Database Documentation; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2018.
- Healthcare Cost and Utilization Project (HCUP) CCS. 2017. Available online: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp (accessed on 9 June 2018).
- Clinton, H.A.; Hunter, A.A.; Logan, S.B.; Lapidus, G.D. Evaluating opioid overdose using the National Violent Death Reporting System, 2016. Drug Alcohol Depend. 2019, 194, 371–376. [Google Scholar] [CrossRef] [PubMed]
- Young, A.M.; Glover, N.; Havens, J.R. Nonmedical use of prescription medications among adolescents in the United States: A systematic review. J. Adolesc. Health 2012, 51, 6–17. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez-Llera, M.C.; Domingo-Salvany, A.; Brugal, M.T.; Silva, T.C.; Sánchez-Niubó, A.; Torrens, M.; Itinere Investigators. Psychiatric comorbidity in young heroin users. Drug Alcohol Depend. 2006, 84, 48–55. [Google Scholar] [CrossRef] [PubMed]
- Ruhm, C.J. Drug involvement in fatal overdoses. SSM Popul. Health 2017, 3, 219–226. [Google Scholar] [CrossRef] [PubMed]
- Warner, M.; Trinidad, J.P.; Bastian, B.A.; Miniño, A.M.; Hedegaard, H. Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2010–2014. Natl. Vital. Stat. Rep. 2016, 65, 1–15. [Google Scholar] [PubMed]
- Trim, R.S.; Chassin, L. Neighborhood socioeconomic status effects on adolescent alcohol outcomes using growth models: Exploring the role of parental alcoholism. J. Stud. Alcohol Drugs 2008, 69, 639–648. [Google Scholar] [CrossRef] [PubMed]
- Gaither, J.R.; Shabanova, V.; Leventhal, J.M. US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999–2016. JAMA Network Open 2018, 1, e186558. [Google Scholar] [CrossRef] [PubMed]
- Kane, J.M.; Colvin, J.D.; Bartlett, A.H.; Hall, M. Opioid-Related Critical Care Resource Use in US Children’s Hospitals. Pediatrics 2018, 141, e20173335. [Google Scholar] [CrossRef] [PubMed]
- Substance Abuse and Suicide: A Guide to Understanding the Connection and Reducing Risk. Available online: https://www.drugrehab.com/guides/suicide-risks/ (accessed on 15 May 2019).
- Dragisic, T.; Dickov, A.; Dickov, V.; Mijatovic, V. Drug Addiction as Risk for Suicide Attempts. Mater. Sociomed 2015, 27, 188–191. [Google Scholar] [CrossRef] [PubMed]
- Opioid Overdose. 2018. Available online: https://www.cdc.gov/drugoverdose/opioids/heroin.html (accessed on 15 May 2019).
- Yule, A.M.; Lyons, R.M.; Wilens, T.E. Opioid Use Disorders in Adolescents-Updates in Assessment and Management. Curr. Pediatr. Rep. 2018, 6, 99–106. [Google Scholar] [CrossRef] [PubMed]
- Ho, R.C.; Chen, K.Y.; Broekman, B.; Mak, A. Buprenorphine: aspects of prescription, misuse and service provision from a global perspective. Adv. Psychiatr. Treat. 2009, 15, 354–363. [Google Scholar] [CrossRef]
- Ho, R.C.; Ho, E.C.; Tan, C.H.; Mak, A. Pulmonary Hypertension in First Episode Infective Endocarditis among Intravenous Buprenorphine Users. Am. J. Drug Alcohol Abus. 2009, 35, 199–202. [Google Scholar] [CrossRef]
- Ho, R.C.; Ho, E.C.; Mak, A. Cutaneous Complications among Intravenous Buprenorphine Users. J. Dermatol. 2009, 36, 24–31. [Google Scholar] [CrossRef] [PubMed]
- Normile, B.; Hanlon, C.; Eichner, H. State Strategies to Meet the Needs of Young Children and Families Affected by the Opioid Crisis; The National Academy for State Health Policy: Washington, DC, USA, 2018. [Google Scholar]
- Intervention IDEAs for Infants Toddlers Children and Youth Impacted by Opioids. Available online: https://osepideasthatwork.org/sites/default/files/IDEAslIssBrief-Opioids-508.pdf (accessed on 15 May 2019).
Variable | Non-HOD (%) | HOD (%) | OR | 95% CI | p Value |
---|---|---|---|---|---|
Total inpatients | 27,442,808 | 1432 | - | - | - |
Age at admission, in years | |||||
<11 | 88.9 | 4.6 | Reference | ||
12–18 | 11. | 95.4 | 56.38 | 43.36–73.30 | <0.001 |
Sex | |||||
Male | 51.0 | 57.2 | 1.46 | 1.30–1.64 | <0.001 |
Female | 49.0 | 42.8 | Reference | ||
Race | |||||
White | 51.3 | 81.0 | Reference | ||
Black | 15.8 | 1.9 | 0.18 | 0.12–0.27 | <0.001 |
Hispanic | 21.4 | 10.8 | 0.80 | 0.66–0.97 | 0.023 |
NA/Asian | 11.5 | 6.3 | 0.97 | 0.77–1.23 | 0.819 |
Median household income, in percentile | |||||
0–25th | 29.0 | 12.6 | Reference | ||
26th–50th | 25.1 | 20.9 | 1.41 | 1.15–1.72 | 0.001 |
51st–75th | 24.6 | 26.5 | 1.77 | 1.47–2.14 | <0.001 |
76th–100th | 21.3 | 40.0 | 2.38 | 1.99–2.84 | <0.001 |
Comorbid psychiatric disorders | |||||
Anxiety disorders | 1.4 | 20.4 | 1.21 | 1.05–1.40 | 0.010 |
Mood disorders | 3.0 | 43.8 | 1.06 | 0.930–1.21 | 0.386 |
Suicidality | 1.0 | 3.1 | 0.19 | 0.14–0.25 | <0.001 |
Psychotic disorders | 0.3 | 1.0 | 0.42 | 0.25–0.70 | 0.001 |
Comorbid substance use disorders | |||||
Tobacco | 0.6 | 36.8 | 1.73 | 1.51–1.98 | <0.001 |
Cannabis | 0.6 | 28.5 | 0.83 | 0.72–0.96 | 0.011 |
Opioid | 0.1 | 62.4 | 195.68 | 167.71–228.32 | <0.001 |
Amphetamine | 0 | 7.1 | 1.03 | 0.81–1.32 | 0.814 |
Cocaine | 0 | 9.4 | 1.45 | 1.12–1.76 | <0.001 |
Variable | 2010 (%) | 2011 (%) | 2012 (%) | 2013 (%) | 2014 (%) | p Value |
---|---|---|---|---|---|---|
Total inpatients | 289 | 258 | 295 | 305 | 235 | - |
Age at admission, in years | ||||||
<11 | 5.5 | 0 | 3.3 | 3.2 | 11.3 | 0.001 |
12–18 | 94.5 | 100.0 | 96.7 | 96.8 | 88.7 | |
Sex | ||||||
Male | 60.9 | 61.2 | 49.2 | 57.1 | 58.5 | 0.336 |
Female | 39.1 | 38.8 | 50.8 | 42.9 | 41.5 | |
Race | ||||||
White | 80.9 | 79.1 | 77.2 | 91.2 | 75.0 | 0.726 |
Black | 0 | 4.0 | 3.5 | 1.8 | 0 | |
Hispanic | 13.0 | 8.4 | 12.3 | 5.3 | 15.9 | |
NA/Asian | 6.1 | 8.4 | 7.0 | 1.8 | 9.1 | |
Median household income, in percentile | ||||||
0–25th | 12.5 | 12.3 | 13.6 | 17.7 | 5.8 | 0.294 |
26th–50th | 21.9 | 30.4 | 13.6 | 16.1 | 25.0 | |
51st–75th | 24.3 | 22.5 | 28.8 | 25.8 | 30.8 | |
76th–100th | 41.3 | 34.8 | 44.1 | 40.3 | 38.5 | |
Comorbid psychiatric disorders | ||||||
Anxiety disorders | 20.8 | 18.2 | 16.4 | 25.4 | 20.8 | 0.329 |
Mood disorders | 40.5 | 40.7 | 49.2 | 42.9 | 45.3 | 0.221 |
Suicidality | 1.7 | 1.9 | 4.9 | 1.6 | 5.7 | 0.032 |
Psychotic disorders | 3.5 | 0 | 1.6 | 0 | 0 | <0.001 |
Comorbid substance use disorders | ||||||
Tobacco | 28.7 | 40.3 | 32.8 | 44.4 | 37.7 | 0.009 |
Cannabis | 28.8 | 22.9 | 32.8 | 30.2 | 26.4 | 0.773 |
Opioid | 46.9 | 55.6 | 65.6 | 74.6 | 67.9 | <0.001 |
Amphetamine | 5.2 | 6.6 | 6.6 | 11.1 | 5.7 | 0.201 |
Cocaine | 7.3 | 7.4 | 9.8 | 11.1 | 11.3 | 0.032 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Queeneth, U.; Bhimanadham, N.N.; Mainali, P.; Onyeaka, H.K.; Pankaj, A.; Patel, R.S. Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders. Behav. Sci. 2019, 9, 77. https://doi.org/10.3390/bs9070077
Queeneth U, Bhimanadham NN, Mainali P, Onyeaka HK, Pankaj A, Patel RS. Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders. Behavioral Sciences. 2019; 9(7):77. https://doi.org/10.3390/bs9070077
Chicago/Turabian StyleQueeneth, Uwandu, Narmada N. Bhimanadham, Pranita Mainali, Henry K. Onyeaka, Amaya Pankaj, and Rikinkumar S. Patel. 2019. "Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders" Behavioral Sciences 9, no. 7: 77. https://doi.org/10.3390/bs9070077
APA StyleQueeneth, U., Bhimanadham, N. N., Mainali, P., Onyeaka, H. K., Pankaj, A., & Patel, R. S. (2019). Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders. Behavioral Sciences, 9(7), 77. https://doi.org/10.3390/bs9070077